About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
- WOMEN
- 2026 Readers' Choice Awards
Classifieds
Weather
Obituaries
2026 Readers' Choice Winners

Recent Quotes

View Full List

My Watchlist

Capstone Energy Plus, Inc. - Common Stock

Lict Corp

Telo Genomics Corp

Edit Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

Design Therapeutics, Inc. - Common Stock (NQ:DSGN)

9.750 -0.880 (-8.28%)

Delayed Quote Updated: 3:57 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Design Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

What to Know About This Fund's $10 Million Bet on Gold Miners ↗

May 24, 2026

ASA Gold and Precious Metals Limited targets global mining equities, specializing in gold, silver, and other precious minerals investments.

Via The Motley Fool

Topics Economy

Which stocks are moving on Wednesday? ↗

April 29, 2026

Via Chartmill

Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗

November 20, 2025

Via Benzinga

Earnings Preview For Design Therapeutics ↗

March 18, 2024

Via Benzinga

Steven Cohen's Biotech Bets Are Getting Bolder — And Smaller ↗

August 29, 2025

Billionaire hedge fund manager Steven Cohen is diving into small-cap biotech with new stakes in two clinical-stage companies, signaling confidence in their potential for outsized returns.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 28, 2025

Via Benzinga

Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

February 19, 2025

Via Benzinga

Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket ↗

February 18, 2025

Via Benzinga

Top movers in Friday's pre-market session ↗

February 14, 2025

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Monday's pre-market session: top gainers and losers ↗

February 10, 2025

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 21, 2025

Via Benzinga

Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

December 31, 2024

Via Benzinga

Why Cemtrex Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

December 31, 2024

Via Benzinga

MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

December 26, 2024

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday.

Via Benzinga

Topics Stocks

Lamb Weston Posts Weak Q2 Results, Joins Micron, Lennar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

December 19, 2024

Via Benzinga

Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

December 19, 2024

Via Benzinga

The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains ↗

May 22, 2024

Biotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them.

Via InvestorPlace

DSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024 ↗

May 08, 2024

DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 07, 2024

Via Benzinga

Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying ↗

March 26, 2024

The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023 ↗

March 19, 2024

DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For March 19, 2024 ↗

March 19, 2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 09, 2024

Via Benzinga

Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

August 31, 2023

The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...

Via Benzinga

Topics Stocks

Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch ↗

August 17, 2023

All three leading U.S. stock indices — the S&P 500, Nasdaq 100, and Russell 2000 — have simultaneously breached a crucial technical support level this week.

Via Benzinga

Topics Stocks

Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments ↗

August 15, 2023

RBC Capital Market downgraded Design Therapeutics Inc (NASDAQ: DSGN) from Outperform to Sector Perform with a price target of $7,

Via Benzinga

Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher ↗

August 15, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded down 0.82% to 35,017.95 while the NASDAQ fell 0.77% to 13,682.54. The...

Via Benzinga

Topics Stocks

Why Shares of Design Therapeutics Are Plummeting on Tuesday ↗

August 15, 2023

The biotech company released phase 1 trial details regarding a Friedreich ataxia therapy.

Via The Motley Fool

Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 15, 2023

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Design Therapeutics, Inc. - Common Stock (NQ:DSGN)

Headline News about Design Therapeutics, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us